| Financial Year |
March 31 2023 |
| Monetary Funds |
128,153,661.90 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
10,199,952.02 |
| Accounts Receivable |
95,623,488.25 |
| Advances to Suppliers |
1,394,136.58 |
| Other Receivables |
226,982.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
104,468,340.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,026,896.91 |
| Total Current Assets |
376,539,301.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
207,023,843.69 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,961,258.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,839,536.06 |
| Deferred Income Tax Assets |
1,423,006.80 |
| Other Non-Current Assets |
1,088,660.00 |
| Sub-Total of Non-Current Assets |
245,336,304.90 |
| Total Assets |
621,875,606.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,604,711.51 |
| Accounts Payable |
106,690,765.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,367,288.61 |
| Taxes Payable |
2,441,162.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
168,889.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
12,686,462.24 |
| Sub-Total of Current Liabilities |
132,503,734.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
546,521.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,117,910.17 |
| Total Liabilities |
137,621,644.99 |
| Paid-In Capital(Or Share Stock) |
140,000,000.00 |
| Capital Surplus |
82,568,097.27 |
| Surplus Reserve |
30,126,343.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
231,559,520.18 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
484,253,961.19 |
| Owner's Equity（Stockholder's Equity） |
484,253,961.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
621,875,606.18 |
